期刊文献+

乙型肝炎病人血清转化生长因子α水平检测及其临床意义 被引量:1

The clinical significance of monitoring serum transforming growth factor-alpha level in hepatitis B
下载PDF
导出
摘要 目的 通过对不同病程的乙型肝炎病人血清转化生长因子α(TGF α)的检测 ,探讨TGF α的变化规律及其与肝功能损害的关系 ,并对TGF α在乙型肝炎诊断中的临床意义进行初步观察。方法 采用放射免疫分析法测定了 84例乙型肝炎患者血清TGF α含量 ,同时检测了各项肝功能指标。所获数据利用计算机SPSS软件应用方差分析及相关分析法进行统计学处理。结果 ①急性肝炎、慢性肝炎 (中度 )、慢性肝炎 (重度 )病人血清TGF α含量分别为 13 744± 4 449pg/ml、12 815± 5 2 2 5pg/ml、15 892± 5 0 94pg/ml,明显高于对照组 8 3 95± 3 10 7pg/ml(P <0 0 1) ;慢性肝炎 (轻度 )病人血清TGF α含量为 8 517± 2 719pg/ml,与对照组比较差异无统计学意义 (P >0 0 5)。②肝病病人血清TGF α的变化与肝功能指标ALT、AST、ALB呈正相关关系 ,而与AKP、γ GT无关。结论 血清TGF α的检测对乙型肝炎的预后估计具有重要临床意义 ,且TGF ObjectiveTo study the relationship betwee n the changes of transforming growth factor-alpha(TGF-α) and liver function dam age in different phases of hepatitis B and the clinical significance of measur ing the level of TGF-α in patients with different phases of liver diseases.MethodsThe method of RIA and auto-biochemistry instrument we re employed to detect the serum TGF-α level and liver function index in 84 pat ients. Results①All the patients were divid ed into 5 groups according to different phase and severity of liver diseases,acu te hepatitis,chronic hepatitis (mild),chronic hepatitis (moderate),chronic hepat itis (severe).The levels of serum TGF-α were (13 744±4 449) pg/ml,(8 517± 2 7 19) pg/ml,(12 815±5 225) pg/ml,(15 892±5 049) pg/ml,(8 396±3 107) pg/ml r espectively.Except that of chronic hepatitis (mild),the level of serum TGF-α i n other groups were much higher than control group ( P <0.01) ②Serum TGF-α was positively correlated with serum level of ALT,AST,ALB( P <0.05) and had no relationship with the level of AKP,γ-GT( P >0.05). ConclusionsThe level of serum TGF-α may be associated with the p rognosis of hepatitis B.The increasing level of TGF-α,reflecting the damage of liver f unction may provide useful information for the diagnosis of phases in hepatitis B.
出处 《胃肠病学和肝病学杂志》 CAS 2003年第5期473-474,共2页 Chinese Journal of Gastroenterology and Hepatology
关键词 乙型肝炎 血清 转化生长因子Α 临床意义 肝功能损害 放射免疫分析法 预后 Transforming growth factor-alpha Hepatitis B Liver function
  • 相关文献

参考文献5

  • 1[1]Masuhara M, Yasunage M, Tanigawa K, et al. Expression of hepatocyte growth factor, transforming growth factor-alpha, transforming growth factor-βmessenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Hepatocty, 1996,24 (2): 232-329.
  • 2[2]Park BC, Huh MH, Seo JH. Differential expression of transforming growth factor α and insulin-like growth factor Ⅱ in chronic active hepatitis B cirrhosis and hepatocellular carcinoma. J Hepatol, 1995,22 (3): 286-294.
  • 3[3]Bartom CM,Hall PA Hughes CM et al. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol, 1991, 163(2) :111-116.
  • 4[4]Tanaka S,Takenaka K, Matsumata T,et al. Hepatitis C virus replication is accociated with expression of transforming growth factor-alpha and insulinlike growth factor Ⅱ in cirrhotic livers. Dig Dis Sci, 1996,41 ( 1 ) :208-215.
  • 5[5]Tomiya T, Fujiwara K. Serum Transforming Growth Factor α Lever as a Marker of Hepathocellular carcinoma complication. Cancer, 1996, 77 (6): 1056-1060.

同被引文献21

  • 1骆抗先.乙型肝炎基础和临床(第2版)[M].北京:人民卫生出版社,2001.415-435.
  • 2Merican l,Guan R,Amarapuka D,et al. SPECIAL REPORT:Chronic hepatitis B virus infection in Asian countries[J].Journal of Gastroenterology and Hepatology, 2000,15 : 1356.
  • 3Crowley SJ, Tognarini D. Desmond PV, et al. Cost -- effectiveness analysis of lamivudine for the treatment of chronic hepatitis B[J]. Pharmacoeconomics, 2000.17 (5) : 409.
  • 4Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome[J]. Alimentary Pharmacology&Therapeutics,2001,15(4) : 439.
  • 5Groeneweg M, Moerland W. Quero JC, et al. Screening of subclinical hepatic encephalopathy[J].J Hepatol, 2000,32 (5) : 748.
  • 6Park CK, Park SY, Kim ES, et al. Assessment of quality of life and associated factor patients with chronic viral liver disease[J]. Taehan Kan Hakhoe Chi,2003,9(3) : 212.
  • 7Ian M, Gralnek MD, Ron D, et al. Development and evaluation of the liver disease quality of life instrument in persons with advaneed, chronic liver disease the LDQOL 1.0[J]. The Atnerican .Journal of Gastroenterology, 2000,95 ( 12 ) : 3552.
  • 8Giulio Marchesini, Giampaolo Bianhchi, Piero Amodio, et al.Factors associated with poor health--related quality of life of patients with cirrhosis[J]. Gastroenterology, 2001,120 : 170.
  • 9Younossi ZM, Boparai N, Price LL, et al. Assessment of utilities and health--related quality of life in patients with chronic liver disease [J]. The American Journal of Gastroenterology.2001,96(2) : 579.
  • 10潘化平.慢性乙型肝炎患者生存质量的测量与评价[J].肝脏,2001,6(2):86-88. 被引量:12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部